The first Report "Medicines use in the elderly population in Italy", produced by the Medicines Utilisation Monitoring Centre (OsMed) with the coordination of the Italian Medicines Agency (AIFA) and the Istituto Superiore di Sanità (ISS) was presented at the Sala delle Colonne of the Angelicum ...
The data collected and analysed concern the reports of suspected adverse reactions registered in the National Pharmacovigilance Network between 27 December 2020 and 26 September 2021 for the four vaccines used in the current vaccination campaign.
Produced by the National Observatory on the Use of Medicines (OsMed) with the coordination of AIFA and the Istituto Superiore di Sanità, the Report will be presented on Wednesday 13 October 2021 at 10.00
The Italian Medicines Agency has sent a letter to the President of the Puglia Region, Michele Emiliano, on the case of the two children with SMA1 for whom the administration of Zolgensma therapy is requested
AIFA’s Scientific Technical Committee (CTS), at its meeting on 7-9 September 2021, expressed its opinion on the administration of additional doses of vaccine against COVID-19, answering the questions posed by the Ministry of Health.
AIFA strongly denies the totally false news according to which, after the authorisation by the Agency for the use of some monoclonal antibodies against COVID-19, the marketing authorisation for COVID vaccines issued by the EMA has been withdrawn.